Guided Antiplatelet Therapy in Interventional Treatment of Intracranial Aneurysms

NACompletedINTERVENTIONAL
Enrollment

590

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

October 3, 2023

Study Completion Date

October 29, 2023

Conditions
Intracranial Aneurysm
Interventions
DRUG

Adjustment of Antiplatelet Drugs

The maximum platelet aggregation rate induced by arachidonic acid (AA-MPA)≥20%, give aspirin 200mg qd. The maximum platelet aggregation rate induced by adenosine diphosphatase (ADP-MPA)≥36.4% for flow diversion, give ticagrelor 60mg bid. ADP-MPA≥42.9% for stent-assisted coil embolization,give ticagrelor 60mg bid. ADP-MPA\<20%, give clopidogrel 37.5mg qd. The timing of drug adjustment should be at least 1 day before stent implantation, and the LTA testing should be performed again 48 hours after the drug adjustment. For patients whose ADP-MPA does not reach the normal range, a second antiplatelet drug adjustment should be performed: ticagrelor overdose: reduce to 45mg bid; ticagrelor resistance, increase to 90 mg bid.

Trial Locations (2)

100070

Beijing Tiantan hospital, Beijing

Department of Neurosurgery, Beijing Tiantan Hospital., Beijing

All Listed Sponsors
collaborator

Xuanwu Hospital, Beijing

OTHER

collaborator

Chinese PLA General Hospital

OTHER

collaborator

Beijing Chao Yang Hospital

OTHER

collaborator

Peking University International Hospital

OTHER

collaborator

Peking University First Hospital

OTHER

collaborator

Hebei Medical University Third Hospital

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

lead

Beijing Tiantan Hospital

OTHER

NCT05825391 - Guided Antiplatelet Therapy in Interventional Treatment of Intracranial Aneurysms | Biotech Hunter | Biotech Hunter